Pluri (PLUR) FCF Margin (QoQ) (2011 - 2025)
Pluri (PLUR) FCF Margin (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Pluri | 16.11 Mn | 3.63 Mn | 86,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -110,012.00 |
| Sep 30, 2025 | -26,272.00 |
| Jun 30, 2025 | -34,885.00 |
| Mar 31, 2025 | 141,931.00 |
| Dec 31, 2024 | -125,173.00 |
| Sep 30, 2024 | 319,270.00 |
| Jun 30, 2024 | 154,054.00 |
| Mar 31, 2024 | -245,319.00 |
| Dec 31, 2023 | 744,656.00 |
| Sep 30, 2023 | -833,974.00 |
| Jun 30, 2023 | 430,845.00 |
| Mar 31, 2023 | 31.04 Mn |
| Dec 31, 2022 | -30.86 Mn |
| Dec 31, 2018 | 19.60 Mn |
| Dec 31, 2015 | 396,097.00 |
| Dec 31, 2014 | -241,053.00 |
| Sep 30, 2014 | 196,527.00 |
| Jun 30, 2014 | -92,212.00 |
| Mar 31, 2014 | -118,105.00 |
| Dec 31, 2013 | 236,842.00 |